Transcatheter Tricuspid Valve Interventions After Heart Transplantation

H eart transplantation (HTx) is a destination procedure for selected patients with endstage heart failure.The enhanced median survival of HTx patients is up to 13 years, 1 and incorporation into the HTx program of marginal donorsthose with elderly status or associated comorbidities including diabetes, hypertension, left ventricular hypertrophy, mild coronary artery, or valvular heart disease-has led to the emergence of late complications after HTx such as valvular and conduction system disease.2 For HTx patients, with their unique physiology and relatively limited life span, quality of life takes From the Department of Interventional Cardiology, Eternal Hospital, Jaipur, Rajasthan, India.The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate.For more information, visit the